powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1922419928
Rita Medina
M.D.
Infectious Disease
Valdosta,
GA
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
Healthparse Signals
Monitor this provider for changes — dated NPI change events
QUALITY · MIPS · 2024
Final MIPS score
100.0
Quality
13.5
Cost
74.6
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
1.05%
Group
PRESCRIBING · PART D · 2024
Total Rx claims
776
Beneficiaries
—
Total drug cost
$1.7M
Distinct drugs
22
Brand share
71.8%
Top prescribed drugs
Bictegrav/Emtricit/Tenofov Ala
188 claims
Abacavir/Dolutegravir/Lamivudi
129 claims
Daptomycin
62 claims
Ceftriaxone Sodium
48 claims
Atazanavir Sulfate
34 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
282
Unique beneficiaries
—
Total services
460
Distinct HCPCS
6
Medicare payment
$42K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 177 Infectious Disease providers in GA — below median (cohort median 600).
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$64
Payment records
3
By payment type
Food and Beverage
$64
Top paying entities
Food and Beverage
$64
